$LLY 0.47 Noisy

Notable posts

• @Mr_Derivatives bullish 985 eng

  🚨 The CEO of $LLY just bought ~$2M worth of $ADBE stock yesterday… Whoa. Insiders sell for a number of reasons. But they buy for just one reason… https://t.co/yg7qFTa7H5

  view on X →
• @WOLF_Financial neutral 704 eng

  HERE ARE THE WORLD'S 50 MOST VALUABLE COMPANIES AS OF JUNE 2026 TECHNOLOGY (22 of the top 50): NVIDIA $NVDA: $4.8T Apple $AAPL: $4.3T Alphabet $GOOGL: $4.2T Microsoft $MSFT: $2.8T SpaceX $SPCX: $2.1T TSMC $TSM: $2.3T Broadcom $AVGO: $1.8T Samsung: $1.5T Meta $META: $1.4T SK Hynix: $1.2T Micron $MU: $1.2T AMD $AMD: $848B Intel $INTC: $665B ASML $ASML: $685B Arm $ARM: $391B Cisco $CSCO: $478B Oracle $ORCL: $476B Applied Materials $AMAT: $465B Lam Research $LRCX: $464B KLA $KLAC: $319B Tencent: $485B Kioxia: $313B CONSUMER DISCRETIONARY: Amazon $AMZN: $2.5T Tesla $TSLA: $1.4T Home Depot $HD: $324B ENERGY: Saudi Aramco: $1.7T ExxonMobil $XOM: $579B Chevron $CVX: $350B FINANCIALS: Berkshire Hathaway $BRK: $1.1T JPMorgan Chase $JPM: $895B Visa $V: $625B Mastercard $MA: $431B Bank of America $BAC: $411B Morgan Stanley $MS: $357B Goldman Sachs $GS: $323B China Construction Bank: $382B Agricultural Bank of China: $326B ICBC: $308B HSBC $HSBC: $328B CONSUMER STAPLES: Walmart $WMT: $950B Costco $COST: $425B Procter & Gamble $PG: $351B Coca-Cola $KO: $346B HEALTH CARE: Lilly $LLY: $987B Johnson & Johnson $JNJ: $576B AbbVie $ABBV: $415B UnitedHealth $UNH: $372B INDUSTRIALS: Caterpillar $CAT: $453B P&G $PG: $351B (also listed under consumer staples) GE $GE: $372B (Photo Credit: VisualCapitalist)

  view on X →
• @WOLF_Financial neutral 600 eng

  This is how the largest US listed stocks have performed so far in 2026 Nvidia $NVDA +10%🟢 Apple $AAPL +13.1%🟢 Google $GOOGL +17.7%🟢 Microsoft $MSFT -13.8%🔴 Amazon $AMZN +6.6%🟢 Tawian Semi $TSM +36.6%🟢 Broadcom $AVGO +11.5%🟢 Meta Platforms $META -10.2%🔴 Tesla $TSLA -13.1%🔴 Eli Lilly $LLY +5.3%🟢 Berkshire Hathaway $BRK.B -2.9%🔴 Micron $MU +202.7%🟢 Walmart $WMT +6.7%🟢 JPMorgan $JPM -3.1%🔴 $AMD +117.8%🟢

  view on X →
• @cevikfinance bullish 501 eng

  Böyle sert düşen günler sağlam şirketlere uzun vadeli eklemeler yapmak için harika fırsatlar. İşte bu sağlam şirketlere bazı örnekler: $MU $AMD $TSM $GEV $CRDO $ALAB $MRVL $ASML $AVGO $CEG $VST $ANET $VRT $TER $FIX $PWR $CLS $LLY $PLTR $NBIS $SOFI $HOOD $APP $COHR $RKLB $GLW $LRCX $BE $DELL Yatırım tavsiyesi değildir, her zaman kendi araştırmanızı yapınız!

  view on X →
• @wallstengine neutral 294 eng

  Eli Lilly $LLY is reportedly in talks to acquire psychedelic drugmaker AtaiBeckley $ATAI, per Bloomberg. A deal could be announced as soon as this week. AtaiBeckley has a market value of about $2B, and Lilly is reportedly negotiating at a premium. The key asset is BPL-003, a fast-acting nasal spray for treatment-resistant depression that has FDA Breakthrough Therapy designation. Bloomberg Intelligence estimates the psychedelic treatment market could reach $7B in sales by 2032.

  view on X →
• @enrichtrades bullish 176 eng

  Watchlist for tomorrow, 7/10: $DELL & $HOOD both ran 50%+ today Still seeing plenty of A+ setups. Let price action confirm: $TSLA $META $RDDT $HOOD $UBER $ARM $ANET $LLY $DELL $IBM Stay disciplined. This is the time to capitalize.🤞

  view on X →
• @Mr_Derivatives bullish 163 eng

  $LLY ATH’s today off Trump mention. Wow

  view on X →
• @wallstengine neutral 162 eng

  Eli Lilly $LLY agreed to acquire AtaiBeckley $ATAI for up to $3.8B. Terms: $6.75/share cash upfront, valuing AtaiBeckley at about $2.8B, plus a CVR worth up to $2.50/share tied to BPL-003 and VLS-01 milestones. The upfront price is a roughly 40% premium to $ATAI’s 30-day VWAP. Key asset: BPL-003, an intranasal 5-MeO-DMT therapy for treatment-resistant depression with FDA Breakthrough Therapy designation and Phase 3 activity underway. Deal expected to close in Q3 2026.

  view on X →